Alliance Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Alliance Pharma

Access the complete profile.

Alliance Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology 621511 Medical Laboratories
Address	17 Lee Boulevard Malvern, PA 19355

Note: Revenues for privately held companies are statistical evaluations.


Alliance Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Alliance Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Alliance Pharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Alliance Pharma Annual Revenue and Growth Rate

Alliance Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Alliance Pharma's revenues are gauged from an analysis of company filings.

Alliance Pharma's Income Statement (based on Industry Averages)

Alliance Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Alliance Pharma is developing and marketing. Alliance Pharma's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RESOLIAN Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development	02/15/2023
RESOLIAN BIOANALYTICS Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development	02/15/2023
RESOLIAN ANALYTICAL SCIENCES Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development	02/15/2023

See all trademarks and details in the Full Report.

Market Share of Alliance Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alliance Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Alliance Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ENDO PHARMACEUTICALS	Malvern, PA	100
FRONTAGE LABORATORIES	Exton, PA	73
NEURONETICS	Malvern, PA	21
REACTION BIOLOGY	Malvern, PA	16
ALLIANCE PHARMA	Malvern, PA	14
OCUGEN	Malvern, PA	10

Future Competition: Alliance Pharma's Fastest Growing Competitors

These companies are in the same general field as Alliance Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)